REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
17/03/2025
Voltar para busca
Dado oficial do USPTO
POPTISELECT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
49
Atualização mais recente
17/03/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 42
Data de depósito
09/01/2019
Data de registro
17/03/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/03/2020
Última transação
17/03/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
27
Localização do titular
DE
Examinador
HUSSAIN, TASNEEM
Unidade examinadora
O30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
CEVEC Pharmaceuticals GmbH
Representantes
Dyan M. House Baker & Mckenzie, LLP
Classificação técnica
Classes Nice
Classe 1Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalbiological and biochemical substancespreparations and reagents for scientific researchlaboratory researchindustrial and commercial purposesexcept chromatography chemicals and mediaexcept chemicals for use in separation and purification; chemicalbiological and biochemical substancespreparations and reagents for researching and characterizing diseases except chromatography chemicals and mediaexcept chemicals for use in separation and purification; chemicalbiological and biochemical substancespreparations and reagents for scientific and medical research and drug development except chromatography chemicals and mediaexcept chemicals for use in separation and purification; chemicalbiological and biochemical substancespreparations and reagents for manufacturing drugs and pharmaceuticalsexcept chromatography chemicals and mediaexcept chemicals for use in separation and purification; cultures of microorganismsproteinspolypeptidesnucleotidesnucleic acidsin particular plasmidseukaryotic cell lines and eukaryotic cellsin particular transfected and/or selected eukaryotic cell lines and eukaryotic cells for scientific researchlaboratory researchindustrial and commercial purposes; all of the foregoing other than for medical or veterinary purposes
Classe 42
Scientific and industrial researchin particular in the fields of medicinepharmacymolecular biologybiotechnology and genetics; research and development of drugsdiagnostic and analytical preparationstherapy procedures and expression systems; scientific and technological research and development services and related consultancyin particular in the field of medicinepharmacymolecular biologybiotechnology and genetics; scientific research and development relating to the cultivationextractionoptimizationsynthesizing and modifying of eukaryotic cell lineseukaryotic cellsmicroorganismspolypeptidesproteinsnucleotidesnucleic acidsfor third partiesin particular for use in the field of medicinepharmacymolecular biologybiotechnology and genetics; scientific researchanalysis and development services relating to the breedingobtainingoptimizingsynthesizing and modifying eukaryotic cell lineseukaryotic cellsin particular transfected and selected eukaryotic cells and eukaryotic cell lines with a nucleic acidin particular a plasmidfor third partiesin particular for use in the field of medicinepharmacymolecular biologybiotechnology and genetics; scientific analysis and development of transfected eukaryotic cells and eukaryotic cell lines for third partiesin particular for use in the field of medicinepharmacymolecular biologybiotechnology and genetics; all afore mentioned services except services relating to capture and intermediate purification of proteins
Publicações
Histórico de despachos e eventos da marca no USPTO.
49 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/10/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/08/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/08/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/08/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/08/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/08/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/08/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
19/11/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/08/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
21/08/2023
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
21/08/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/08/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/08/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
21/08/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
21/08/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/07/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
13/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/07/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/06/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/06/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/06/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/06/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/08/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
27/07/2020
FIMP
FINAL DISPOSITION PROCESSED
27/07/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/06/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
17/03/2020
GPNX
NOTIFICATION PROCESSED BY IB
04/01/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/12/2019
PUBO
PUBLISHED FOR OPPOSITION
31/12/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/12/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
18/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/12/2019
ALIE
ASSIGNED TO LIE
20/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/11/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/11/2019
RFNP
REFUSAL PROCESSED BY IB
14/06/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/05/2019
RFRR
REFUSAL PROCESSED BY MPU
25/05/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/04/2019
MAFR
APPLICATION FILING RECEIPT MAILED
30/04/2019
CNRT
NON-FINAL ACTION WRITTEN
29/04/2019
DOCK
ASSIGNED TO EXAMINER
26/04/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/04/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
25/04/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace POPTISELECT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.